SNA 007
Alternative Names: SNA-007Latest Information Update: 01 Dec 2021
At a glance
- Originator SmartNuclide Biopharma
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 01 Dec 2021 Early research in Solid tumours in China (unspecified route) (SmartNuclide Biopharma pipeline, December 2021)